Annual Cash & Cash Equivalents
$25.84 M
-$67.10 M-72.20%
31 December 2023
Summary:
Atara Biotherapeutics annual cash & cash equivalents is currently $25.84 million, with the most recent change of -$67.10 million (-72.20%) on 31 December 2023. During the last 3 years, it has fallen by -$174.56 million (-87.11%). ATRA annual cash & cash equivalents is now -87.11% below its all-time high of $200.40 million, reached on 31 December 2020.ATRA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$46.45 M
+$15.14 M+48.35%
30 September 2024
Summary:
Atara Biotherapeutics quarterly cash and cash equivalents is currently $46.45 million, with the most recent change of +$15.14 million (+48.35%) on 30 September 2024. Over the past year, it has dropped by -$18.34 million (-28.30%). ATRA quarterly cash and cash equivalents is now -76.82% below its all-time high of $200.40 million, reached on 31 December 2020.ATRA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.2% | -28.3% |
| 3 y3 years | -87.1% | -59.0% |
| 5 y5 years | -57.4% | -50.8% |
ATRA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -87.1% | at low | -59.0% | +79.8% |
| 5 y | 5 years | -87.1% | at low | -76.8% | +79.8% |
| alltime | all time | -87.1% | +514.2% | -76.8% | +112.1% |
Atara Biotherapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $46.45 M(+48.3%) |
| June 2024 | - | $31.31 M(-10.8%) |
| Mar 2024 | - | $35.09 M(+35.8%) |
| Dec 2023 | $25.84 M(-72.2%) | $25.84 M(-60.1%) |
| Sept 2023 | - | $64.79 M(+41.2%) |
| June 2023 | - | $45.90 M(-5.8%) |
| Mar 2023 | - | $48.74 M(-47.6%) |
| Dec 2022 | $92.94 M(-12.4%) | $92.94 M(+42.7%) |
| Sept 2022 | - | $65.11 M(-7.9%) |
| June 2022 | - | $70.69 M(-30.5%) |
| Mar 2022 | - | $101.67 M(-4.2%) |
| Dec 2021 | $106.08 M(-47.1%) | $106.08 M(-6.3%) |
| Sept 2021 | - | $113.21 M(-8.6%) |
| June 2021 | - | $123.86 M(-18.0%) |
| Mar 2021 | - | $151.10 M(-24.6%) |
| Dec 2020 | $200.40 M(+169.7%) | $200.40 M(+220.0%) |
| Sept 2020 | - | $62.62 M(-16.0%) |
| June 2020 | - | $74.51 M(+6.1%) |
| Mar 2020 | - | $70.20 M(-5.5%) |
| Dec 2019 | $74.32 M | $74.32 M(-21.3%) |
| Sept 2019 | - | $94.43 M(+59.6%) |
| June 2019 | - | $59.16 M(+5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $56.17 M(-7.5%) |
| Dec 2018 | $60.70 M(-23.4%) | $60.70 M(-8.1%) |
| Sept 2018 | - | $66.03 M(-36.0%) |
| June 2018 | - | $103.20 M(+14.0%) |
| Mar 2018 | - | $90.50 M(+14.2%) |
| Dec 2017 | $79.22 M(+65.2%) | $79.22 M(+31.0%) |
| Sept 2017 | - | $60.49 M(-5.8%) |
| June 2017 | - | $64.24 M(+2.9%) |
| Mar 2017 | - | $62.43 M(+30.1%) |
| Dec 2016 | $47.97 M(+102.0%) | $47.97 M(+4.2%) |
| Sept 2016 | - | $46.01 M(+74.6%) |
| June 2016 | - | $26.36 M(+19.5%) |
| Mar 2016 | - | $22.06 M(-7.1%) |
| Dec 2015 | $23.75 M(+8.4%) | $23.75 M(-56.4%) |
| Sept 2015 | - | $54.47 M(+108.0%) |
| June 2015 | - | $26.19 M(-63.3%) |
| Mar 2015 | - | $71.33 M(+225.7%) |
| Dec 2014 | $21.90 M(-57.6%) | $21.90 M(-14.8%) |
| Sept 2014 | - | $25.70 M(-19.1%) |
| June 2014 | - | $31.78 M(-20.1%) |
| Mar 2014 | - | $39.75 M(-23.0%) |
| Dec 2013 | $51.62 M(+1126.9%) | $51.62 M |
| Dec 2012 | $4.21 M | - |
FAQ
- What is Atara Biotherapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual cash & cash equivalents year-on-year change?
- What is Atara Biotherapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly cash and cash equivalents year-on-year change?
What is Atara Biotherapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ATRA is $25.84 M
What is the all time high annual cash & cash equivalents for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual cash & cash equivalents is $200.40 M
What is Atara Biotherapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ATRA annual cash & cash equivalents has changed by -$67.10 M (-72.20%)
What is Atara Biotherapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ATRA is $46.45 M
What is the all time high quarterly cash and cash equivalents for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly cash and cash equivalents is $200.40 M
What is Atara Biotherapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ATRA quarterly cash and cash equivalents has changed by -$18.34 M (-28.30%)